Business
Puma Biotechnology Added to the NASDAQ Biotechnology Index (NBI)
LOS ANGELES, December 22, 2025--Puma Biotechnology was added to the Nasdaq Biotechnology Index effective after the close of trading on Dec. 19, 2025.
About this update from Puma Se
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":2400,"height":800,"url":"https://media.zenfs.com/en/business-wire.com/b18e86259f61d3f0892789f929feca25"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/QTIAYX2Mb37PR1qf9Db_7g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMyMDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/b18e86259f61d3f0892789f929feca25","width":960,"height":320},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/ZufC3hpqzmVWtHTEQDlHWw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD04MDA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/b18e86259f61d3f0892789f929feca25","width":1200,"height":400}},"lazy":false},{"type":"text","content":"LOS ANGELES, December 22, 2025--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that it has been added to the Nasdaq Biotechnology Index (NASDAQ: NBI), effective at the close of trading on Friday, December 19, 2025.","length":264,"tagName":"p"},{"type":"text","content":""Our inclusion in the Nasdaq Biotechnology Index is an important recognition of Puma’s continued commercial execution, profitability, and clinical progress," said Alan H. Auerbach, Chairman, Chief Executive Officer, and President of Puma. "With sustained demand for NERLYNX® and advancing development of alisertib, we believe this milestone enhances our visibility within the biotechnology investment community as we remain focused on delivering value for patients and shareholders."","length":503,"tagName":"p"},{"type":"text","content":"The NBI is designed to track the performance of a set of securities listed on The Nasdaq Stock Market® that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark. Companies in the NBI must meet eligibility requirements, including minimum market capitalization, average daily trading volume and seasoning as a public company, among other criteria. The NBI is evaluated annually in December and is calculated under a modified capitalization-weighted methodology.","length":514,"tagName":"p"},{"type":"text","content":"For more information about the Nasdaq Biotechnology Index, please visit: https://indexes.nasdaqomx.com/Index/Overview/NBI.","length":122,"tagName":"p"},{"type":"text","content":...